Massachusetts Personal Injury Lawyer Blog

FDA recommends more study of diabetes drug

    Massachusetts attorney Thomas M. Kiley concentrates on legal issues regarding defective products.  A recent article in The Boston Globe announced that a federal panel of experts is recommending long-term studies of a diabetes drug from Bristol-Myers Squibb be conducted before it is approved by the Federal Food and Drug Administration for use.

    The article describes a federal panel investigating the drug Onglyza that is made by Bristol-Myers and partner AstraZeneca used to treat people with Type 2 diabetes.  A panel of diabetes experts is investigating diabetes drugs.  The FDA recently issued new safety guidelines for diabetes treatments and this panel is investigating each of the drugs used.  In 2007 there were concerns about the drug Avandia made by GlaxoSmithKline that may have heightened the risk of heart attacks.  According to the article, the testing done on this new drug did not include testing of people with already existing heart conditions and the new FDA guidelines require this to ensure the patient's safety.

     For more information, go to http://www.tomkileylaw.com/library/FDA-recommends-more-study-of-diabetes-drug.cfm.